CASI Pharmaceuticals Stock Price

-0.0018 (-0.14%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
CASI Pharmaceuticals Inc CASI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0018 -0.14% 1.2482 12:13:47
Open Price Low Price High Price Close Price Prev Close
1.26 1.22 1.27 1.25
Bid Price Ask Price Spread News
1.24 1.25 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,016 3,236,589 $ 1.25 $ 4,030,435 - 1.135 - 3.90
Last Trade Time Type Quantity Stock Price Currency
12:13:47 400 $ 1.2482 USD


Draw Mode:

CASI Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 174.50M 139.80M 112.13M $ 15.14M $ - -0.44 -2.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -209.54k 4.60%

more financials information »

CASI Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CASI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.331.41061.191.265,934,787-0.0818-6.15%
1 Month1.54181.741.191.373,625,721-0.2936-19.04%
3 Months1.481.741.1351.412,162,516-0.2318-15.66%
6 Months2.022.421.1351.642,052,940-0.7718-38.21%
1 Year1.543.901.1351.811,269,757-0.2918-18.95%
3 Years5.155.19991.1352.11592,065-3.90-75.76%
5 Years1.208.89160.912.84489,5380.04824.02%

CASI Pharmaceuticals Description

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing innovative therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA. The company primarily operates in the United States, Canada, China and other parts of the world.

Your Recent History
CASI Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.